GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » EV-to-FCF

Peptron (XKRX:087010) EV-to-FCF : -64.24 (As of Jun. 08, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Peptron EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Peptron's Enterprise Value is ₩864,698 Mil. Peptron's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-13,461 Mil. Therefore, Peptron's EV-to-FCF for today is -64.24.

The historical rank and industry rank for Peptron's EV-to-FCF or its related term are showing as below:

XKRX:087010' s EV-to-FCF Range Over the Past 10 Years
Min: -190.28   Med: -20.71   Max: -6.68
Current: -56.83

During the past 10 years, the highest EV-to-FCF of Peptron was -6.68. The lowest was -190.28. And the median was -20.71.

XKRX:087010's EV-to-FCF is ranked worse than
100% of 382 companies
in the Biotechnology industry
Industry Median: 8.405 vs XKRX:087010: -56.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Peptron's stock price is ₩41750.00. Peptron's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-775.000. Therefore, Peptron's PE Ratio for today is At Loss.


Peptron EV-to-FCF Historical Data

The historical data trend for Peptron's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron EV-to-FCF Chart

Peptron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.16 -16.56 -18.25 -11.15 -64.11

Peptron Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.82 -21.33 -51.85 -64.11 -43.85

Competitive Comparison of Peptron's EV-to-FCF

For the Biotechnology subindustry, Peptron's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peptron's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Peptron's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Peptron's EV-to-FCF falls into.



Peptron EV-to-FCF Calculation

Peptron's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=864698.374/-13461.32
=-64.24

Peptron's current Enterprise Value is ₩864,698 Mil.
Peptron's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,461 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peptron  (XKRX:087010) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Peptron's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=41750.00/-775.000
=At Loss

Peptron's share price for today is ₩41750.00.
Peptron's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-775.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Peptron EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Peptron's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Peptron (XKRX:087010) Business Description

Traded in Other Exchanges
N/A
Address
37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines